Literature DB >> 2060220

The repair of full-thickness articular cartilage defects. Immune responses to reparative tissue formed by allogeneic growth plate chondrocyte implants.

N Kawabe1, M Yoshinao.   

Abstract

Growth plate cartilage cultivated in vitro was attached with a fibrin clot to a full-thickness articular cartilage defect on knee joints in allogeneic New Zealand rabbits. The healing of the defects was assessed by gross examination, light microscopy, and immunologic analysis for 24 weeks. Immunologic assessment of cell-mediated immunity, cytotoxicity of a humoral antibody by a 51chromium release assay, and immunofluorescence studies were carried out. During the first two weeks following grafting, healing was excellent in 11 of the 17 defects. From three to 24 weeks, 11 of 42 defects examined had good results. Host lymphocytes had accumulated around the allograft at two to 12 weeks. Most of the implanted cartilage grown in vitro died and was replaced by fibrous tissue. The immunologic studies suggested that the implanted cartilage began to degenerate two to three weeks after implantation partially because of a humoral immune response but more importantly because of cell-mediated cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060220

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  15 in total

1.  [In vitro study on the influence of fibrin in cartilage constructs based on PGA fleece materials].

Authors:  H Schmal; A T Mehlhorn; C Kurze; J Zwingmann; P Niemeyer; G Finkenzeller; M Dauner; N P Südkamp; W Köstler
Journal:  Orthopade       Date:  2008-05       Impact factor: 1.087

2.  Advances in Tissue Engineering Techniques for Articular Cartilage Repair.

Authors:  A M Haleem; C R Chu
Journal:  Oper Tech Orthop       Date:  2010-06

3.  The Benefit of Minced Cartilage Over Isolated Chondrocytes in Atelocollagen Gel on Chondrocyte Proliferation and Migration.

Authors:  Yusuke Tsuyuguchi; Tomoyuki Nakasa; Masakazu Ishikawa; Shigeru Miyaki; Ryosuke Matsushita; Munekazu Kanemitsu; Nobuo Adachi
Journal:  Cartilage       Date:  2018-10-12       Impact factor: 4.634

Review 4.  Functionality of decellularized matrix in cartilage regeneration: A comparison of tissue versus cell sources.

Authors:  Yu Sun; Lianqi Yan; Song Chen; Ming Pei
Journal:  Acta Biomater       Date:  2018-04-24       Impact factor: 8.947

5.  Rabbit articular cartilage defects treated by allogenic chondrocyte transplantation.

Authors:  P R J V C Boopalan; Solomon Sathishkumar; Senthil Kumar; Samuel Chittaranjan
Journal:  Int Orthop       Date:  2006-04-11       Impact factor: 3.075

Review 6.  Success rates and immunologic responses of autogenic, allogenic, and xenogenic treatments to repair articular cartilage defects.

Authors:  Christopher M Revell; Kyriacos A Athanasiou
Journal:  Tissue Eng Part B Rev       Date:  2009-03       Impact factor: 6.389

7.  Experimental study of tissue-engineered cartilage allograft with RNAi chondrocytes in vivo.

Authors:  Zhenghui Wang; Xiaoli Li; Xi-Jing He; Xianghong Zhang; Zhuangqun Yang; Min Xu; Baojun Wu; Junbo Tu; Huanan Luo; Jing Yan
Journal:  Ther Clin Risk Manag       Date:  2014-05-08       Impact factor: 2.423

8.  Effects of Hydrostatic Loading on a Self-Aggregating, Suspension Culture-Derived Cartilage Tissue Analog.

Authors:  Jeffrey J Kraft; Changhoon Jeong; John E Novotny; Thomas Seacrist; Gilbert Chan; Marcin Domzalski; Christina M Turka; Dean W Richardson; George R Dodge
Journal:  Cartilage       Date:  2011-07       Impact factor: 4.634

9.  Role of autologous chondrocyte transplantation in articular cartilage defects: An experimental study.

Authors:  Amit Rastogi; Pradeep Srivastava; Zafer Iqbal; Vinay Kumaraswamy; Ravindra Pratap Singh
Journal:  Indian J Orthop       Date:  2013-03       Impact factor: 1.251

Review 10.  Clinical application of scaffolds for cartilage tissue engineering.

Authors:  Junji Iwasa; Lars Engebretsen; Yosuke Shima; Mitsuo Ochi
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-11-20       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.